EE200000638A - 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm - Google Patents

1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm

Info

Publication number
EE200000638A
EE200000638A EEP200000638A EEP200000638A EE200000638A EE 200000638 A EE200000638 A EE 200000638A EE P200000638 A EEP200000638 A EE P200000638A EE P200000638 A EEP200000638 A EE P200000638A EE 200000638 A EE200000638 A EE 200000638A
Authority
EE
Estonia
Prior art keywords
chloronaphth
ylsulfonyl
piperazine
pyridyl
benzoyl
Prior art date
Application number
EEP200000638A
Other languages
English (en)
Inventor
Ashford Marianne
James Roger
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000638A publication Critical patent/EE200000638A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
EEP200000638A 1998-05-02 1999-04-27 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm EE200000638A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809350.3A GB9809350D0 (en) 1998-05-02 1998-05-02 Novel salt
PCT/GB1999/001316 WO1999057112A1 (en) 1998-05-02 1999-04-27 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine

Publications (1)

Publication Number Publication Date
EE200000638A true EE200000638A (et) 2002-04-15

Family

ID=10831311

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000638A EE200000638A (et) 1998-05-02 1999-04-27 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm

Country Status (16)

Country Link
EP (1) EP1084118A1 (et)
JP (1) JP2002513789A (et)
KR (1) KR20010043216A (et)
CN (1) CN1308629A (et)
AU (1) AU3719699A (et)
BR (1) BR9910176A (et)
CA (1) CA2331041A1 (et)
EE (1) EE200000638A (et)
GB (1) GB9809350D0 (et)
HU (1) HUP0102394A3 (et)
IL (1) IL139405A0 (et)
NO (1) NO20005498L (et)
PL (1) PL343705A1 (et)
SK (1) SK16522000A3 (et)
WO (1) WO1999057112A1 (et)
ZA (1) ZA200006036B (et)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9280698A (en) 1997-09-30 1999-04-23 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA56197C2 (uk) * 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
ATE334975T1 (de) * 1997-05-30 2006-08-15 Takeda Pharmaceutical Sulfonamidderivate, ihre herstellung und verwendung
AU9280698A (en) * 1997-09-30 1999-04-23 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives

Also Published As

Publication number Publication date
GB9809350D0 (en) 1998-07-01
SK16522000A3 (sk) 2001-05-10
HUP0102394A3 (en) 2003-01-28
PL343705A1 (en) 2001-08-27
BR9910176A (pt) 2001-01-09
KR20010043216A (ko) 2001-05-25
ZA200006036B (en) 2002-01-25
WO1999057112A1 (en) 1999-11-11
NO20005498D0 (no) 2000-11-01
HUP0102394A2 (hu) 2001-12-28
IL139405A0 (en) 2001-11-25
NO20005498L (no) 2000-11-01
CN1308629A (zh) 2001-08-15
CA2331041A1 (en) 1999-11-11
AU3719699A (en) 1999-11-23
EP1084118A1 (en) 2001-03-21
JP2002513789A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
DE60125980D1 (de) P38kinase-inhibitoren vom piperidin/piperazin-typ
CY2022009I2 (el) Διυδροναφθυριδινες και σχετικες ενωσεις χρησιμες ως αναστολεις κινασης για τη θεραπεια πολλαπλασιαστικων ασθενειων
NO20015746L (no) Ny anvendelse av 1-[4-(5-cyanindol-3-yl)butyl]-4-(2- karbamoylbenzofuran-5-yl)-piperazin og dets fysiologisk akseptablesalter
NO20000115D0 (no) Gastrokinetiske monocykliske benzamider av 3- eller 4- substituerte 4-(aminometyl)-piperidinderivater
CY1109347T1 (el) Συνδυασμος που αποτελειται απο εναν αναστολεα μεταλλαγης σηματος και ενα παραγωγο εποθιλονης
ATE255578T1 (de) Piperazin- und piperidinverbindungen
NO20032315L (no) 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer
SG127737A1 (en) Piperidine and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
IL170314A (en) 4 - (3 -(2 - phenyl - oxazol - 4 - ylmethoxy) - cyclohexyloxy) - butane acid derivatives and related compounds, pharmaceutical compositions comprising them and use thereof
EE200000638A (et) 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm
ATE277053T1 (de) 2-(4-pyridinyl)-benzofurane zur verwendung als metalloprotease-inhibitoren
ID26146A (id) Proses untuk cis-1-{2-[4-(6-metoksi-2-fenil-1,2,3,4-tetrahidronaftalen-1-il]fenoksi]etil} pirolidin
IS8129A (is) Samsetningar paroxetíns og 4-(S)-(4-asetýl-píperasín-1-ýl)-2-(R)-(4-flúor-2-metýl-fenýl)-píperídín-1-karboxýlsýru [1-(R)-(3,5-bis-tríflúormetýl-fenýl)etýl]-metýlamíðs til að meðhöndla þunglyndi og/eða kvíða
AU2000246280A1 (en) Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-carbinols
NO20030658L (no) Fremgangsmåte for modulering av multippel ''lineage'' kinaseproteiner og undersökelse av forbindelser som modulerer multippel "lineage"kinaseproteiner
NO905511L (no) Fremgangsmaate for fremstilling av 1-(4-fluorfenyl)-2-(4-((4-metansulfonamido- eller 4-acetamidofenyl)carbonyl)-1-piperidinyl)-etanon.
DE60224805D1 (de) 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine un
DK1436282T3 (da) Syntese af 4-(piperidyl)(2-pyridyl)methanon(E)-O-methyloxim og dets salte
SI1436282T1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts
AU2002359274A1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts
HK1095273A (en) Combination of (a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2methylphenyl]-4-(3-pyridyl)-2-pyrimidine-amine and (b) at least one hypusination inhibitor and the use thereof
AU2003253173A1 (en) Synthesis of 1-(4-(2-methoxyphenyl) piperazin-1-yl)-3-(2,6-dioxopiperidin-1-yl) propane
HUP0401645A3 (en) Alpha crystal form of 4-(4-methyl-piperazine-1-yl-methyl)-n-[4-methyl-3-(4-pyridine-3-yl)-pyrimidine-2-yl-amino]-phenyl)-benzamide monomethanesulfonate
ZA986167B (en) Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives.
ATA150297A (de) Einrichtung zum ausgleich der höhe von stapeln aus plattenförmigen formatzuschnitten